Medidata Solutions Inc. (MDSO)

69.46
NASDAQ : Technology Services
Prev Close 68.11
Day Low/High 67.61 / 69.56
52 Wk Low/High 59.60 / 88.87
Avg Volume 494.30K
Exchange NASDAQ
Shares Outstanding 61.19M
Market Cap 4.17B
EPS 0.80
P/E Ratio 80.13
Div & Yield N.A. (N.A)

Latest News

Medidata To Present At The 37th Annual J.P. Morgan Healthcare Conference

Medidata To Present At The 37th Annual J.P. Morgan Healthcare Conference

Medidata (NASDAQ:MDSO) today announced that Tarek Sherif, chairman and chief executive officer, and Rouven Bergmann, chief financial officer, will present at the 37th Annual J.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: KALV Downgrades: ECA, ECHO, EROS, FDUS, GVA, HEES, HVT, MDSO, NBLX, PFG, SRE, SVVC, WAT, WCC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Cala Health Streamlines Data And Operational Management For Neurological Device Study With Medidata Cloud

Cala Health Streamlines Data And Operational Management For Neurological Device Study With Medidata Cloud

Medidata (NASDAQ:MDSO) today announced that Cala Health, a neuromodulation platform company developing wearable therapies for chronic disease, is adopting the Medidata Cloud to centralize management of a large observational study.

No Need For End Of Study CDs: Medidata Introduces NEW Rave Digital EOS Media Delivery

No Need For End Of Study CDs: Medidata Introduces NEW Rave Digital EOS Media Delivery

To ease and unify Rave End of Study (EOS) document management, Medidata (NASDAQ:MDSO) today introduced a new, automated function of Edge Regulatory Content Management (RCM).

Medidata Rave Omics Collaboration Uncovers Novel Insights For Rare Disease Research

Medidata Rave Omics Collaboration Uncovers Novel Insights For Rare Disease Research

The Castleman Disease Collaborative Network (CDCN) discovered new patient subgroups, based on previously unknown proteomic signatures, with Medidata's Rave Omics, a machine learning-based solution.

(Graphic: Business Wire)

(Graphic: Business Wire)

Medidata (NASDAQ:MDSO) is pleased to announce that Rave Engage was recognized at the 2018 Scrip Awards as the "Best Technological Development in Clinical Trials - Tech Sponsor Focused.

Federal Court Rejects Veeva's Attack On Medidata's Theft Of Trade Secret Claims

Federal Court Rejects Veeva's Attack On Medidata's Theft Of Trade Secret Claims

The United States District Court for the Southern District of New York has rejected Veeva's motion to dismiss Medidata's complaint against Veeva for theft of trade secrets, the company announced today.

Medidata To Present At Upcoming Investor Conferences

Medidata To Present At Upcoming Investor Conferences

Medidata (NASDAQ:MDSO) today announced its participation in two upcoming investor conferences.

Two Research Studies Supported By Medidata To Be Presented At ASH 2018

Two Research Studies Supported By Medidata To Be Presented At ASH 2018

The Castleman Disease Collaborative Network (CDCN) will present results of a large-scale proteomics study of idiopathic multicentric Castleman disease (iMCD), supported by Medidata Rave Omics, at the 60th Annual Meeting of the American Society of...

Hengrui Pharma Partners With Medidata To Accelerate Global Drug Research

Hengrui Pharma Partners With Medidata To Accelerate Global Drug Research

Medidata (NASDAQ: MDSO) announced that Hengrui Pharma, one of China's largest sponsors, recently adopted Medidata Cloud, the Intelligent Platform for Life Sciences, to accelerate global drug research.

PAREXEL And SHYFT Analytics Partner To Deliver Faster, More Dynamic Real-World Data Studies

PAREXEL And SHYFT Analytics Partner To Deliver Faster, More Dynamic Real-World Data Studies

SHYFT Analytics, a Medidata Solutions (NASDAQ:MDSO) company, and PAREXEL International, a leading innovator of global biopharmaceutical services, today announced that the companies have entered into a strategic partnership that establishes SHYFT's...

ERYTECH Expands Use Of Medidata Cloud To Centrally Manage All Data For Oncology Trials

ERYTECH Expands Use Of Medidata Cloud To Centrally Manage All Data For Oncology Trials

Medidata (NASDAQ: MDSO) today announced that ERYTECH (Euronext: ERYP - Nasdaq: ERYP) expanded its use of the Medidata Cloud, the Intelligent Platform for Life Sciences, to streamline clinical trial operations.

Who's Next?: Acquisition Rumors Abound After IBM's $34 Billion Red Hat Splash

Who's Next?: Acquisition Rumors Abound After IBM's $34 Billion Red Hat Splash

The momentum of acquisitions isn't stalling. Here's what names might be in the mix.

Medidata Honors 2018 Architects Of Hope Award Winners

Medidata Honors 2018 Architects Of Hope Award Winners

Medidata (NASDAQ:MDSO) today announced the winners of the third annual Architects of Hope Awards.

Pharm-Olam Unifies Data On Medidata Cloud, Eliminating Silos

Pharm-Olam Unifies Data On Medidata Cloud, Eliminating Silos

Today at NEXT NYC, Medidata (NASDAQ:MDSO) announced that Pharm-Olam International (Pharm-Olam) signed a new, five-year enterprise agreement to unify operational systems supporting study execution on Medidata Cloud, the Intelligence Platform for Life...

Medidata Sets Major New Corporate Social Responsibility (CSR) Commitments

Medidata Sets Major New Corporate Social Responsibility (CSR) Commitments

Medidata (NASDAQ: MDSO) is committed to creating a better world for patients. The company spent the past year building a corporate social responsibility program dedicated to STEM education, patient advocacy and global inclusion.

Dr. Jill Biden, National Minority Quality Forum, Global Sponsors And CROs Discuss The Future Of Healthcare And Clinical Research At Medidata NEXT NYC 2018

Dr. Jill Biden, National Minority Quality Forum, Global Sponsors And CROs Discuss The Future Of Healthcare And Clinical Research At Medidata NEXT NYC 2018

Medidata NEXT NYC, the premier conference on the digital transformation of life sciences, will feature keynotes from global sponsors and CROs, and Medidata (NASDAQ: MDSO).

Dr. Maria Rivas (Photo: Business Wire)

Dr. Maria Rivas (Photo: Business Wire)

Medidata (NASDAQ: MDSO) announced today that it has appointed Dr. Maria Rivas to its Board of Directors.

Medidata Reports Third Quarter 2018 Results

Medidata Reports Third Quarter 2018 Results

Medidata (NASDAQ:MDSO) today announced its financial results for the third quarter of 2018.

Medidata To Host Investor Day On October 24 In New York

Medidata To Host Investor Day On October 24 In New York

Medidata (NASDAQ:MDSO) today announced that it will hold its Investor Day on October 24, 2018 in New York.

Medidata Cloud Securely Manages Echocardiogram Images For Global Heart Measurement Study

Medidata Cloud Securely Manages Echocardiogram Images For Global Heart Measurement Study

Medidata (NASDAQ:MDSO) today announced that Medidata Cloud, the Intelligent Platform for Life Sciences, is streamlining the management of medical images for the World Alliance of Societies of Echocardiography (WASE) Normal Values Study.

(Graphic: Business Wire)

(Graphic: Business Wire)

More than 15,000 studies have been conducted on the Medidata Cloud, the Intelligent Platform for Life Sciences, Medidata (NASDAQ: MDSO) announced today, making it the industry's largest data repository.

Medidata Announces Third Quarter 2018 Earnings Conference Call

Medidata Announces Third Quarter 2018 Earnings Conference Call

Medidata (NASDAQ: MDSO) today announced that it will release its third quarter 2018 financial results before the market opens on Thursday, October 18, 2018.

Medidata And Decibel Therapeutics Announce Multi-Year Collaboration In Support Of Clinical Development For Hearing Loss, Tinnitus, And Balance Disorders

Medidata And Decibel Therapeutics Announce Multi-Year Collaboration In Support Of Clinical Development For Hearing Loss, Tinnitus, And Balance Disorders

Medidata (NASDAQ:MDSO) today announced that Decibel Therapeutics is adopting Medidata Cloud, the Intelligent Platform for Life Sciences.

Medidata Certified As A Great Place To Work®

Medidata Certified As A Great Place To Work®

Medidata employees take great pride as "Medidatians," according to the 2018 Great Place to Work® survey.

Medidata To Present At Upcoming Investor Conferences

Medidata To Present At Upcoming Investor Conferences

Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.

Hanmi To Streamline Clinical Trials And Bolster Quality Of Results With Medidata Cloud

Hanmi To Streamline Clinical Trials And Bolster Quality Of Results With Medidata Cloud

Hanmi expanded its use of the Medidata Cloud, the Intelligent Platform for Life Sciences, to improve clinical trial efficiency and quality of results, Medidata (NASDAQ:MDSO) announced today.

Medidata Selected For Fortune 100 Fastest-Growing Companies List

Medidata Selected For Fortune 100 Fastest-Growing Companies List

In recognition of three record-performing years, Medidata (NASDAQ: MDSO) was selected for Fortune's 100 Fastest-Growing Companies list.

TheStreet Quant Rating: C+ (Hold)